Direct-from-stool testing for Stx may be suitable for geographies where the local prevalence of STEC infection is significantly higher than in the United States, and for which a loss in analytical sensitivity can be justified by a much higher localized STEC prevalence. Though reducing the turnaround time for Stx detection is an attractive goal to achieve, such a significant loss in analytical sensitivity is difficult to justify for laboratories practicing in regions of low incidence. This is particularly important, since failing to detect STEC can potentially have fatal consequences.
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